The HVTN 505 approach to the changing HIV prevention landscape provided a lot of insight. We know the IPM Dapivirine Vaginal ring received positive opinion from EMA.
What do you think if it were approved as a new HIV prevention tool for women during the PrEPVacc trial?
This reply was modified 3 years, 10 months ago by Jessica Salzwedel.
Dear Mable, i think this would require more engagements with the stakeholders to appreciate the trial design and the scientific value of blinding in clinical trials